Search Continues for Agents to Provide Additive Benefit to Chemoradiation in Head and Neck Cancer
January 21st 2021
Nabil F. Saba, MD, FACP, discusses the results of the JAVELIN Head and Neck 100 trial, as well as data from other key, recent studies in head and neck cancer.